Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry
2007; 20: 386–392.
Schlander M, Trott GE, Schwarz O. The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness. Nervenarzt
2010; 81: 289–300.
Faraone SV, Spencer T, Aleardi M, et al. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol
2004; 24: 24–29.
Schubert I, Koster I, Lehmkuhl G. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000–2007. Dtsch Arztebl Int
2010; 107: 615–621.
Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med
2011; 365: 1896–1904.
Habel LA, Cooper WO, Sox CM, et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA
2011; 306: 2673–2683.
Leslie LK, Alexander ME, Trikalinos TA, et al. Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder. Circ Cardiovasc Qual Outcomes
2008; 1: 134–137.
Buchhorn R, Conzelmann A, Willaschek C, et al. Heart rate variability and methylphenidate in children with ADHD. Atten Defic Hyperact Disord
2012; 4: 85–91.
La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet
1998; 351: 478–484.
Vaseghi M, Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis
2008; 50: 404–419.
Buchhorn R, Muller C, Willaschek C, et al. How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD. ISRN Pharmacol
2012; 2012: 170935.
Roggen A, Pavlovic M, Pfammatter JP. Frequency of spontaneous ventricular tachycardia in a pediatric population. Am J Cardiol
2008; 101: 852–854.
Wang S, Zhu W, Hamilton RM, et al. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm
2010; 7: 1725–1731.
MacLellan-Tobert SG, Porter CJ. Accelerated idioventricular rhythm: a benign arrhythmia in childhood. Pediatrics
1995; 96: 122–125.
Riera AR, Barros RB, de Sousa FD, et al. Accelerated idioventricular rhythm: history and chronology of the main discoveries. Indian Pacing Electrophysiol J
2010; 10: 40–48.
Kinoshita S, Ogawa S, Mitsuoka T. Reverse effects of exercise on the sinus and parasystolic cycle lengths. J Electrocardiol
1996; 29: 131–137.
Kinoshita S, Mitsuoka T. Effect of standing on ventricular parasystole: shortening of the parasystolic cycle length. Heart
1997; 77: 133–137.
Lanza GA, Lucente M, Rebuzzi AG, et al. Ventricular parasystole: a chronobiologic study. Pacing Clin Electrophysiol
1986; 9: 860–867.
Prasad S, Furr AJ, Zhang S, et al. Baseline values from the electrocardiograms of children and adolescents with ADHD. Child Adolesc Psychiatry Ment Health
2007; 1: 11.
Fazio G, Novo G, Sutera L, et al. Sympathetic tone and ventricular tachycardia. J Cardiovasc Med (Hagerstown)
2008; 9: 963–966.
Rosen MR, Hoffman BF. The vagus and the ventricles. Circ Res
1978; 42: 1.
Wilens TE, Prince JB, Spencer TJ, et al. Stimulants and sudden death: what is a physician to do?
2006; 118: 1215–1219.
Batra AS, Alexander ME, Silka MJ. Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason. Pediatr Cardiol
2012; 33: 394–401.